欢迎关注凯莱英要闻随着全球药企陆续披露2025年Q2财报,各企业H1营收情况浮出水面。H1营收排名依次是:强生、罗氏、默沙东、艾伯维、辉瑞、礼来、阿斯利康、诺华、拜耳、BMS。总体来讲,强生以456.36亿美元营收依然领跑MNC,礼来凭借大爆减重产品替尔泊肽实现业绩增长41%,飞跃入榜居第6位。TOP10外还有诺和诺德、赛诺菲、GSK紧随其后。整体来看,2025年上半年MNC的业绩表现基本勾勒出...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.